Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Open-Label, Non-Randomized Trial of Cisplatin Chemotherapy in Patients With BRCA1-Positive Metastatic Breast Cancer

NCT01611727 is registered in ClinicalTrials.gov with Pomeranian Medical University Szczecin as lead sponsor.

NCT NCT01611727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01611727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Open-Label, Non-Randomized Trial of Cisplatin Chemotherapy in Patients With BRCA1-Positive Metastatic Breast Cancer
Lead sponsor
Pomeranian Medical University Szczecin
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2007
Completion date
April 30, 2009
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, metastatic breast cancer